Suppr超能文献

大鼠组织中内皮素-1结合位点和蛙皮素S6B结合位点的体外放射自显影研究

In vitro autoradiographic endothelin-1 binding sites and sarafotoxin S6B binding sites in rat tissues.

作者信息

Kohzuki M, Johnston C I, Abe K, Chai S Y, Casley D J, Yasujima M, Yoshinaga K, Mendelsohn F A

机构信息

Second Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.

出版信息

Clin Exp Pharmacol Physiol. 1991 Jul;18(7):509-15. doi: 10.1111/j.1440-1681.1991.tb01485.x.

Abstract
  1. The distribution of binding sites for [125I]-labelled endothelin-1 ([125I]-ET-1) and [125I]-labelled sarafotoxin S6B ([125I]-SRT) was visualized in rat tissues using in vitro autoradiography. 2. A high density of endothelin-1 (ET-1) binding was found in the heart. In the kidney, ET-1 binding occurred in association with glomeruli, proximal tubules, the inner stripe and inner medulla. In the adrenal, a high density of ET-1 binding occurred in the medulla as well as the zona glomerulosa. 3. The binding affinity constant (KA) for ET-1 binding in these sites ranged from 1 to 10 x 10(9)/mol per litre. 4. Although sarafotoxin S6B (SRT) was 10-100-fold weaker than ET-1 in displacing [125I]-ET-1 from these sites, 1 mumol/L unlabelled SRT completely abolished [125I]-ET-1 binding in all sites. Other venom peptides did not affect [125I]-ET-1 binding. 5. The pattern of [125I]-SRT receptor binding in rat tissues by in vitro autoradiography was identical to that for ET-1 receptor binding, and both unlabelled SRT and unlabelled ET-1 fully competed with [125I]-SRT for binding. 6. These results provide evidence that SRT binds to the ET receptor in a range of rat tissues. The results suggest that there may be subclasses of ET receptors which can be distinguished by the relative potencies of ET-1 and SRT at various tissues.
摘要
  1. 使用体外放射自显影技术在大鼠组织中观察了[125I]标记的内皮素-1([125I]-ET-1)和[125I]标记的沙罗毒素S6B([125I]-SRT)结合位点的分布。2. 发现心脏中内皮素-1(ET-1)结合位点密度高。在肾脏中,ET-1结合与肾小球、近端小管、内带和髓质内带相关。在肾上腺中,髓质和球状带中ET-1结合位点密度高。3. 这些位点中ET-1结合的亲和力常数(KA)范围为1至10×10⁹/摩尔每升。4. 虽然沙罗毒素S6B(SRT)从这些位点取代[125I]-ET-1的能力比ET-1弱10 - 100倍,但1微摩尔/升未标记的SRT完全消除了所有位点的[125I]-ET-1结合。其他毒液肽不影响[125I]-ET-1结合。5. 通过体外放射自显影技术观察到大鼠组织中[125I]-SRT受体结合模式与ET-1受体结合模式相同,未标记的SRT和未标记的ET-1都能与[125I]-SRT完全竞争结合。6. 这些结果提供了证据表明SRT在一系列大鼠组织中与ET受体结合。结果表明可能存在ET受体亚类,可通过ET-1和SRT在不同组织中的相对效力来区分。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验